Patents by Inventor Francisco M. Marty

Francisco M. Marty has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11692212
    Abstract: Methods for diagnosing, treating, and monitoring the treatment of invasive aspergillosis (IA) are described. The methods can include detecting the presence of one or more volatile organic compounds (VOCs) in the breath of subjects suspected of having IA.
    Type: Grant
    Filed: April 12, 2021
    Date of Patent: July 4, 2023
    Assignee: The Brigham and Women's Hospital, Inc.
    Inventors: Sophia Koo, Horatio R. Thomas, Lindsey R. Baden, Francisco M. Marty
  • Publication number: 20220049281
    Abstract: Methods for diagnosing, treating, and monitoring the treatment of invasive aspergillosis (IA) are described. The methods can include detecting the presence of one or more volatile organic compounds (VOCs) in the breath of subjects suspected of having IA.
    Type: Application
    Filed: April 12, 2021
    Publication date: February 17, 2022
    Inventors: Sophia Koo, Horatio R. Thomas, Lindsey R. Baden, Francisco M. Marty
  • Publication number: 20210239680
    Abstract: Methods for diagnosing, treating, and monitoring the treatment of invasive aspergillosis (IA) are described. The methods can include detecting the presence of one or more volatile organic compounds (VOCs) in the breath of subjects suspected of having IA.
    Type: Application
    Filed: October 13, 2020
    Publication date: August 5, 2021
    Inventors: Sophia Koo, Horatio R. Thomas, James Constantine Comolli, Preshious Rearden, Lindsey R. Baden, Francisco M. Marty
  • Patent number: 10444123
    Abstract: Methods for diagnosing, treating, and monitoring the treatment of Clostridium difficile infections (CDI), e.g., Clostridium difficile-Associated Diarrhea (CDAD). The methods can include detecting the presence of one or more volatile organic compounds (VOCs) in a sample from ambient air or stool sample from subjects suspected of having a CDI, e.g., CDAD.
    Type: Grant
    Filed: August 3, 2015
    Date of Patent: October 15, 2019
    Assignee: The Brigham and Women's Hospital, Inc.
    Inventors: Sophia Koo, Lindsey Robert Baden, Francisco M. Marty
  • Publication number: 20190203256
    Abstract: Methods for diagnosing, treating, and monitoring the treatment of invasive aspergillosis (IA) are described. The methods can include detecting the presence of one or more volatile organic compounds (VOCs) in the breath of subjects suspected of having IA.
    Type: Application
    Filed: March 11, 2019
    Publication date: July 4, 2019
    Inventors: Sophia Koo, Horatio R. Thomas, Lindsey R. Baden, Francisco M. Marty
  • Patent number: 10227629
    Abstract: Methods for diagnosing, treating, and monitoring the treatment of invasive aspergillosis (IA) are described. The methods can include detecting the presence of one or more volatile organic compounds (VOCs) in the breath of subjects suspected of having IA.
    Type: Grant
    Filed: June 4, 2015
    Date of Patent: March 12, 2019
    Assignee: The Brigham and Women's Hospital, Inc.
    Inventors: Sophia Koo, Horatio R. Thomas, Lindsey R. Baden, Francisco M. Marty
  • Publication number: 20190033290
    Abstract: Methods for diagnosing, treating, and monitoring the treatment of invasive aspergillosis (IA) are described. The methods can include detecting the presence of one or more volatile organic compounds (VOCs) in the breath of subjects suspected of having IA.
    Type: Application
    Filed: June 26, 2018
    Publication date: January 31, 2019
    Inventors: Sophia Koo, Horatio R. Thomas, James Constantine Comolli, Preshious Rearden, Lindsey R. Baden, Francisco M. Marty
  • Patent number: 10031125
    Abstract: Methods for diagnosing, treating, and monitoring the treatment of invasive aspergillosis (IA) are described. The methods can include detecting the presence of one or more volatile organic compounds (VOCs) in the breath of subjects suspected of having IA.
    Type: Grant
    Filed: September 6, 2013
    Date of Patent: July 24, 2018
    Assignees: The Brigham and Women's Hospital, Inc., The Charles Stark Draper Laboratory, Inc.
    Inventors: Sophia Koo, Horatio R. Thomas, James Constantine Comolli, Preshious Rearden, Lindsey R. Baden, Francisco M. Marty
  • Publication number: 20170227429
    Abstract: Methods for diagnosing, treating, and monitoring the treatment of Clostridium difficile infections (CDI), e.g., Clostridium difficile-Associated Diarrhea (CDAD). The methods can include detecting the presence of one or more volatile organic compounds (VOCs) in a sample from ambient air or stool sample from subjects suspected of having a CDI, e.g., CDAD.
    Type: Application
    Filed: August 3, 2015
    Publication date: August 10, 2017
    Inventors: Sophia Koo, Lindsey Robert Baden, Francisco M. Marty
  • Publication number: 20170107556
    Abstract: Methods for diagnosing, treating, and monitoring the treatment of invasive aspergillosis (IA) are described. The methods can include detecting the presence of one or more volatile organic compounds (VOCs) in the breath of subjects suspected of having IA.
    Type: Application
    Filed: June 4, 2015
    Publication date: April 20, 2017
    Inventors: Sophia Koo, Horatio R. Thomas, Lindsey R. Baden, Francisco M. Marty
  • Publication number: 20150233895
    Abstract: Methods for diagnosing, treating, and monitoring the treatment of invasive aspergillosis (IA) are described. The methods can include detecting the presence of one or more volatile organic compounds (VOCs) in the breath of subjects suspected of having IA.
    Type: Application
    Filed: September 6, 2013
    Publication date: August 20, 2015
    Inventors: Sophia Koo, Horatio R. Thomas, James Constantine Comolli, Preshious Rearden, Lindsey R. Baden, Francisco M. Marty